News & Analysis on Clinical Trial Services & Contract Research And Development
Cytopia has received the green light to trial a promising new drug that could prove effective in the fight against advanced solid tumours. In animal studies, the drug candidate has already shown efficacy in killing cancer cells in prostate, colon and...
The use of positron emission tomography (PET) and small animal imaging has the potential to eliminate more strenuous drug development trials with animals, creating a viable alternative.
Isis Pharmaceuticals is developing its first inhaled antisense drug for the treatment of asthma and related pulmonary diseases. The drug represents a potentially effective therapy for these diseases that continue to see cases rising in Europe and the US.
The ongoing Interphex show in New York has seen continued evidence of the expansion of disposable technologies into areas of bioprocessing currently dominated by multi-use items, reports Phil Taylor.
The European Centre for the Validation of Alternative Methods (ECVAM), part of the Joint Research Centre (JRC), is seeking to reduce animal testing as part of the upcoming EU directive that aims to abolish animal testing in scientific experiments if...